Nancy J Hutson
CIK 1379222 · last filed 2025-06-16
Nancy J Hutson is a corporate insider who has filed 107 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BCRX, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$3.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $768.3K across reported positions. 17 SEC filings were submitted jointly with CUBIST PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BCRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STONINGTON, CT 06378
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 99,138 | $7.75 | $768.3K | -$2.02M | 40 | 2025-06-16 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 6,200 | $0.35 | $2.2K | $90.3K | 12 | 2024-06-21 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 37,760 | $0.07 | $2.6K | $22.9K | 9 | 2022-05-20 |
| Endo International plc (ENDP) Delisted | Director | 117,140 | $0.29 | $34.3K | -$605.2K | 21 | 2021-06-15 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | -$585.0K | 2 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 9,847 | — | — | -$834.4K | 13 | 2013-07-29 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | 0 | — | — | $98.4K | 7 | 2011-05-16 |
Recent Filings
107 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | BCRX | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-12-16 | BCRX | Sell (S) | −7,000 | -$52.8K | EDGAR |
| 2024-12-13 | BCRX | Notice (144) | −7,000 | -$52.6K | EDGAR |
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | BCRX | Grant (A) | +6,820 | $0 | EDGAR |
| 2024-05-22 | BCRX | Buy (P) | +5,000 | $31.9K | EDGAR |
| 2023-10-04 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +10,000 | $8.6K | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | BCRX | Mixed | +3,879 | -$103.4K | EDGAR |
| 2023-06-14 | BCRX | Notice (144) | −12,866 | -$104.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.